共 26 条
[1]
[2]
[3]
[4]
[5]
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models; and Early Evidence of Clinical Brain Metastases Activity[J] Peter Ballard;James W.T. Yates;Zhenfan Yang;Dong-Wan Kim;James Chih-Hsin Yang;Mireille Cantarini;Kathryn Pickup;Angela Jordan;Mike Hickey;Matthew Grist;Matthew Box;Peter Johnstr?m;Katarina Varn?s;Jonas Malmquist;Kenneth S. Thress;Pasi A. J?nne;Darren Cross <journal-title>Clinical Cancer Research 2016,
[6]
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma[J] T. Iuchi;M. Shingyoji;T. Sakaida;K. Hatano;O. Nagano;M. Itakura;H. Kageyama;S. Yokoi;Y. Hasegawa;K. Kawasaki;T. Iizasa Lung Cancer 2013,
[7]
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation[J] S.J. Park;H.T. Kim;D.H. Lee;K.P. Kim;S.-W. Kim;C. Suh;J.S. Lee Lung Cancer 2012,
[8]
Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases: Prospective Evaluation of Target Margin on Tumor Control[J] Clara Y.H. Choi;Steven D. Chang;Iris C. Gibbs;John R. Adler;Griffith R. Harsh;Robert E. Lieberson;Scott G. Soltys International Journal of Radiation Oncology; Biology; Physics 2012,
[9]
Radiosurgery for Large Brain Metastases[J] Jung Ho Han;Dong Gyu Kim;Hyun-Tai Chung;Sun Ha Paek;Chul-Kee Park;Hee-Won Jung International Journal of Radiation Oncology; Biology; Physics 2012,
[10]
Stereotactic Irradiation of the Postoperative Resection Cavity for Brain Metastasis: A Frameless Linear Accelerator-Based Case Series and Review of the Technique[J] Paul J. Kelly;Yijie Brittany Lin;Alvin Y. Yu;Brian M. Alexander;Fred Hacker;Karen J. Marcus;Stephanie E. Weiss International Journal of Radiation Oncology; Biology; Physics 2012,

